. NLRs comprise a large receptor family that is characterized by the presence of a conserved NOD motif 3, 4 . Notably, the domain structure of NLRs resembles that of a subset of plant disease-resistance (R) genes, which trigger the hypersensitive response and confer resistance of plants to infection with fungal, viral, parasitic and insect pathogens 5 . The general domain organization of NLRs includes: an amino-terminal effector binding region that consists of protein-protein interaction domains, such as the caspase-recruitment domain (CARD), pyrin domain (PYD) or baculovirus inhibitor repeat (BIR) domain; an intermediary NOD that is needed for nucleotide binding and self-oligomerization; and an array of carboxy-terminal leucine-rich repeat (LRR) motifs that are presumed to detect conserved microbial patterns and to modulate NLR activity. Bioinformatics studies have shown that there are 22 NLR genes in the human genome and at least 34 NLR genes in the mouse genome 3, 4 . The current model proposes that when a PAMP -or danger-associated molecular pattern (DAMP) -is sensed by the C-terminal LRR motifs of an NLR, the molecule undergoes conformational rearrangements that trigger oligomerization through the NOD. In turn, NLRs expose the N-terminal effector domains to induce the recruitment and activation of CARD-and/or PYD-containing effector molecules by promoting their spatial proximity and oligomerization. As a result, NLRs are involved in the activation of diverse signalling pathways. For example, the NLR proteins NOD1 and NOD2 interact with the receptor-interacting serine-threonine protein kinase 2 (RIPK2; also known as RICK or RIP2) to induce nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signalling. Furthermore, NOD1 and NOD2 have been shown to control the induction of autophagy by recruiting autophagy-related gene 16-like 1 (ATG16L1) to the plasma membrane 6 . NOD2 also associates with mitochondrial antiviral signalling protein (MAVS; also known as VISA, CARDIF or IPS1) for the induction of type I interferons (IFNs) in response to viral infection Nature Reviews | Immunology (NLRX1) and NLRC5 have been shown to inhibit NF-κB-and type I IFN-mediated signalling pathways, indicating that these NLRs have important roles as negative regulators for the homeostatic control of innate immunity 8, 9 . Clearly, NLRs and inflammasomes participate in a diverse set of innate immune signalling pathways (FIG. 1) .
Our understanding of the crucial roles of NLRs and inflammasomes in mounting protective antiviral immune responses and the molecular mechanisms that are used by viral pathogens to evade them has progressed remarkably in the past few years. Depending on the nature of the infectious agent, particular NLRs and activate nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and inflammasomes to initiate signalling cascades that lead to the production of pro-inflammatory cytokines, thereby amplifying antiviral innate immune responses. In the presence of viral PAMPs, NLR family PYD-containing protein 3 (NLRP3) and absent in melanoma 2 (AIM2) oligomerize and recruit the adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) through homotypic pyrin domain (PYD) interactions. The caspase-recruitment domain (CARD) of ASC binds the CARD of pro-caspase-1, leading to caspase-1 activation and the production of interleukin-1β (IL-1β) and IL-18 through cleavage of pro-IL-1β and pro-IL-18. Retinoic acid inducible gene-I (RIG-I) contains an RNA helicase domain and an amino-terminal CARD. The helicase domain of RIG-I senses the 5ʹ-triphosphate moiety of single-stranded (ss)RNA virus genomes and then signals through CARD-CARD interactions with the adaptor molecule mitochondrial antiviral signalling protein (MAVS). This results in the phosphorylation and activation of interferon (IFN) response factor 3 (IRF3) and IRF7 to turn on the transcription of type I IFN (IFNα/β) genes. RIG-I also regulates IL-1β production transcriptionally and post-translationally following recognition of 5ʹ-triphosphate double-stranded (ds)RNA. Whereas RIG-I-triggered transcription of pro-IL-1β depends on nuclear factor-κB (NF-κB) activation and is mediated by MAVS, inflammasome formation, caspase-1 activation, and IL-1β and IL-18 production in response to RIG-I activation involve ASC. The NLRs NOD2, NLR family member X1 (NLRX1) and NLR family CARD-containing protein 5 (NLRC5) associate with MAVS. Whereas NOD2 mediates the induction of type I IFNs, NLRX1 and NLRC5 inhibit RIG-I-MAVS interactions and thereby negatively regulate type I IFN production. LRR, leucine-rich repeat; MAPK, mitogen-activated protein kinase; MYD88, myeloid differentiation primary-response protein 88; RIPK2, receptor-interacting serine-threonine protein kinase 2; ROS, reactive oxygen species; TLR, Toll-like receptor; TNF, tumour necrosis factor; TRIF, TIR-domain-containing adaptor protein inducing IFNβ. 
Autophagy
An evolutionarily conserved process in which acidic double-membrane vacuoles sequester intracellular contents (such as damaged organelles and macromolecules) and target them for degradation through fusion to secondary lysosomes.
inflammasome complexes become activated to elicit tailored immune responses. Here, I review recent findings on the roles of the inflammasome components NLRP3, RIG-I and AIM2 and the NLRs NOD2, NLRX1 and NLRC5 in activating or inhibiting antiviral signalling pathways and discuss the crosstalk that exists between these PRRs. Finally, I provide a brief overview of the mechanisms of viral evasion of these pathways.
Inflammasome activation during viral infection
A breakthrough in our understanding of the mechanisms that control the activation of inflammatory caspases came from the identification and characterization of the inflammasome, a large (~700 kDa) multiprotein complex that recruits inflammatory caspases and triggers their activation 10 . Inflammasomes are often defined by their constituent PRR family member, which functions as a scaffold protein to bring caspase-1 molecules together and mediate proximity-induced auto-activation of caspase-1. Currently, three distinct inflammasome complexes have been shown to be involved in antiviral immunity: the NLRP3 inflammasome [11] [12] [13] [14] [15] , the RIG-I inflammasome 16 and the AIM2 inflammasome [17] [18] [19] . In these complexes, the bipartite, 22 kDa adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) provides a link between NLRP3, RIG-I or AIM2 and the pro-form of caspase-1 through homotypic interactions with N-terminal PYD motifs and C-terminal CARD motifs (FIG. 2) . Activated caspase-1 cleaves pro-IL-1β and pro-IL-18 into biologically active IL-1β and IL-18. After secretion from the cell, IL-1β and IL-18 induce various biological effects that are associated with infection, inflammation and autoimmune processes 20, 21 . Whereas most cytokines traffic through the Golgi complex before exocytosis, biologically active IL-1β and IL-18 are secreted through an unconventional and ill-defined mechanism following cleavage of their cytosolic precursors by caspase-1 (REF. 22 ). IL-1β participates in the generation of systemic and local responses to infection, injury and immunological challenge by generating fever, activating lymphocytes and promoting leukocyte infiltration at sites of injury or infection 20 . IL-18 lacks the pyrogenic activity of IL-1β and its main function seems to be the induction of IFNγ production by activated T cells and natural killer (NK) cells, thereby contributing to T helper 1 (T H 1) cell polarization 22, 23 . Many viruses activate caspase-1 and induce IL-1β and IL-18 production (TABLE 1) . In recent studies with a mouse-adapted strain of influenza A/PR/8/34 virus, mice that were deficient for IL-1 receptor type 1 (Il1r1 -/-mice) had impaired viral clearance at days 7 and 10 after infection and a 33% increase in mortality compared , absent in melanoma 2 (AIM2) and retinoic acid inducible gene-I (RIG-I) assemble caspase-1-activating inflammasome complexes in response to microbial pathogenassociated molecular patterns (PAMPs). The NLRP3 inflammasome senses the presence of multiple PAMPs, including viral RNA, in combination with ATP, ion flux and/or reactive oxygen species. By contrast, AIM2 and RIG-I directly bind to double-stranded (ds)DNA and single-stranded (ss)RNA viral genomes, respectively. All three types of inflammasome induce caspase-1 activation and interleukin-1β (IL-1β) and IL-18 production. The adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) is required in all inflammasome complexes to bridge the interaction between upstream PRRs and inflammatory caspases through its amino-terminal pyrin domain (PYD) and carboxy-terminal caspaserecruitment domain (CARD), respectively. To interfere with inflammasome signalling, the large genomes of poxviruses encode multiple inhibitors, such as PYD and SPI-2, which inhibit ASC and caspase-1, respectively. Influenza virus NS1 protein inhibits both caspase-1 and mitochondrial antiviral signalling protein (MAVS) (FIG. 1) . IL-1R1, IL-1 receptor type 1; IL-1RAP, IL-1 receptor accessory protein; LRR, leucine-rich repeat. with wild-type controls. In addition, neutrophil and lymphocyte recruitment to the infected respiratory tract of Il1r1 -/-mice was decreased at day 7 after infection, although it was comparable to the wild-type control mice by day 10 after infection. In addition, there were greatly decreased IgM levels in both the serum and lung at days 7 and 10 after infection in Il1r1 -/-mice 24 .
Similar to Il1r1
-/-mice, Il18 -/-mice also had slightly increased mortality, enhanced virus growth, increased neutrophil recruitment to the respiratory tract and increased nitric oxide production during the first 3 days after respiratory challenge with influenza A/PR/8/34 virus 25 . However, after challenge with a less virulent form of influenza A virus, IL-18 deficiency was associated with decreased cytokine production by CD8 + T cells 26 . In addition to infection with influenza A virus, IL-1β-deficient mice were also more susceptible to herpes simplex virus 1 (HSV1)-mediated encephalitis owing to increased viral load, decreased inflammation, including fewer infiltrating immune cells, and decreased cytokine and chemokine levels 27 . Ectromelia virus, an orthopoxvirus, activates caspase-1 in the brain tissue of infected mice and this is thought to have a role in mediating inflammation and cell death 28 . Furthermore, West Nile virus (WNV) infection causes the migration of resident skin dendritic cells, known as Langerhans cells, to the draining lymph nodes. The migration of Langerhans cells requires IL-1β, as treatment with an IL-1β-specific neutralizing antibody decreased Langerhans cell migration and decreased the total number of immune cells that were recruited to the lymph nodes of WNV-infected mice 29 . Hepatitis B virus (HBV) stimulated IL-18 production by human peripheral blood mononuclear cells by means of the histone-like domain of the viral core antigen (HBVcAg) 30 . Interestingly, HBV virions that were deficient for the precore antigen (HBVeAg) induced higher levels of IL-18, indicating a role for HBVeAg in the inhibition of IL-18 production. Respiratory syncytial virus (RSV) induces the activation of caspase-1 and production of IL-1β, as well as secretion of IL-1β from neonatal human monocytes, possibly implicating one or more types of inflammasome in the response to RSV infection 31 . The fact that a wide range of viruses and diverse viral components activate caspase-1, IL-1β and IL-18 shows the potential role of inflammasomes in the immune response to viruses and research in this direction could provide new insights into the activation mechanisms of inflammasomes and their downstream signalling pathways.
The NLRP3 inflammasome. The first evidence for the involvement of NLR-containing inflammasomes in viral infection came from a study in which Sendai virus and influenza A virus were shown to stimulate caspase-1 activation and the production of IL-1β and IL-18 (REF. 32 ). Subsequent studies have shown that influenza A virus can activate NLRP3 in various cell types in vitro, including mouse bone marrow-derived dendritic cells and macrophages, a human nasal airway epithelial cell line and the human monocyte cell line THP-1 (REFS 11, 12) . In addition to influenza A virus, infection with modified vaccinia virus Ankara 33 or encephalomyocarditis virus (EMCV) 16 has also been shown to activate the NLRP3 inflammasome. However, it should be noted that direct interaction between NLRP3 and viral RNA has not been established. Furthermore, based on the requirement for NLRP3 for IL-1β production in response to infection with EMCV but not with vesicular stomatitis virus (VSV), the data indicate the existence of both NLRP3-dependent and NLRP3-independent mechanisms of caspase-1 activation during viral infection 16 . The requirement for NLRP3 inflammasome activation during virus infection in vivo is best characterized for influenza A virus, although contradictory results have been obtained from different studies. Two recent reports showed a role for NLRP3-mediated immune responses to influenza A virus infection in vivo; Nlrp3 -/-mice had increased mortality compared with wild-type mice in response to virus infection 11, 15 . Deficiency of NLRP3, caspase-1 or the adaptor protein ASC resulted in decreased infiltration of neutrophils and monocytes to the lungs and decreased IL-1β, IL-18 and CXC-chemokine ligand 2 (CXCL2; also known as MIP2) levels in the bronchoalveolar lavage fluid (BALF) of mice infected with influenza A virus 11, 15 . Levels of IL-6, tumour necrosis factor (TNF), CXCL1 (also known as KC) and IFNα were also reported to be decreased in NLRP3-deficient mice that were infected with influenza A virus by one group 15 , whereas the other group reported differential roles for NLRP3 and ASC in inducing the production of CXCL1 and TNF, respectively 11 . These data indicate the existence of inflammasome-dependent paracrine and autocrine immune pathways. Similarly, a delay in influenza A virus clearance at day 7 after infection 11 , compared with no difference in virus clearance at day 6 after infection 15 , for Nlrp3 -/-mice compared with wild-type mice was reported by these groups; the discrepancy might be due to differences in the infectious doses that were used between studies. Finally, the importance of NLRP3 for the resolution of inflammation and the proper repair of lung damage was shown by the observation that Nlrp3 -/-mice that were infected with influenza A virus had increased collagen deposition in the lungs and increased necrosis 15 . These resolution and repair activities of NLRP3 might be mediated directly by IL-1β, as the repair of mechanically injured rat type II alveolar epithelial cell monolayers was promoted by adding IL-1β to in vitro cultures 34 . IL-1β was shown to be the crucial component of oedema fluid that stimulated repair in a lung epithelial cell line, which is consistent with reports that IL-1β can have a pro-fibrotic role in wound healing at particular stages of an infection 35 . It should also be noted that these two studies of the role of NLRP3 in influenza A virus infection 11, 15 observed some slight differences in the severity or magnitude of several outcomes between NLRP3-deficient mice and ASC-or caspase-1-deficient mice, with NLRP3 deficiency having the more severe phenotype in some cases. This was observed in terms of survival by one group 11 and in terms of collagen deposition by the other group 15 , and it was suggested that these results might indicate additional roles for NLRP3 outside of the inflammasome 11 . Furthermore, neither of these reports indicated any role for the NLRP3 inflammasome in the generation of an adaptive immune response to influenza A virus.
In line with the above findings, another study 12 also showed a role for the NLRP3 inflammasome in the immune response to influenza A virus in vitro, as well as in the alveolar space in vivo, as there were decreased levels of IL-1β and IL-18 in the BALF of infected NLRP3-, ASC-or caspase-1-deficient mice 12 . Furthermore, at days 8 and 10 after infection, Asc -/-or caspase-1-deficient mice had higher viral titres and were more susceptible to infection with influenza A virus and had decreased neutrophil and monocyte lung infiltrates compared with wild-type mice 11, 12, 15 . However, this study did not report any difference in cytokine levels, with the exception of IFNγ, in whole lung homogenates for Nlrp3 -/-mice compared with wild-type mice after influenza A virus infection 12 . Decreased CD4 + and CD8 + T cell responses and significantly reduced levels of isotype-specific antibodies were observed in Asc -/-or caspase-1-deficient mice, but not in Nlrp3 -/-mice 12 . Possible explanations for the differences between these reports are the timing of the experiments (days 6, 7, 8, 10 and 11 after infection) and the infectious doses that were used (between 10 and 1,000 plaque-forming units). Together, currently published studies show a role for the NLRP3 inflammasome during influenza A virus infection 11, 15, 36 , but whether NLRP3 is required for adaptive antiviral immunity needs further validation.
Although a role for NLRP3 in sensing viruses has been proposed, the precise molecular mechanism remains poorly understood. Several lines of evidence indicate that the NLRP3 inflammasome might detect the presence of viral RNA and DNA in intracellular compartments. For example, transfection of human and mouse cell lines with ssRNA or dsRNA analogues, such as polyinosinic-polycytidylic acid (poly(I:C)), is sufficient to activate NLRP3 (REF. 11). Similarly, purified dsRNA from rotavirus or brome mosaic virus and ssRNA of influenza A virus also activate NLRP3 (REFS 11, 12, 32) . NLRP3 has also been implicated in the detection of viral DNA from adenovirus in cell culture 37 . Adenovirus vector capsids alone did not activate NLRP3; by contrast, replication-deficient adenovirus vectors with an intact genome activated the NLRP3 inflammasome. In vivo administration of poly(I:C) or purified influenza A virus ssRNA in mice also led to IL-1β secretion and inflammation as a result of NLRP3 activation 11, 13, 15 . The discovery that NLRP3 can detect a wide range of divergent PAMPs -such as bacterial LPS, peptidoglycan and bacterial or viral nucleic acids -as well as endogenous danger signals (DAMPs), such as monosodium urate (MSU), calcium pyrophosphate dihydrate and ATP, has led to the hypothesis that NLRP3 might sense a common downstream effect caused by these molecules, rather than the PAMPs or DAMPs themselves. Reactive oxygen species (ROS) that are generated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase have been proposed as second messengers that activate the NLRP3 inflammasome 11, 38 . This conclusion was based on the pharmacological inhibition of the NADPH oxidase complex in THP-1 cells and peritoneal mouse macrophages, as well as the small interfering RNA (siRNA)-mediated downregulation of the NADPH oxidase subunit p22phox 38 . NLRP3 was also shown to physically interact with a ROS-sensing protein, thioredoxin-interacting protein (TXNIP). This indicates that activation of the NLRP3 inflammasome might have a role in the response to ROS 39 . Furthermore, a role for ROS in inflammasome activation during influenza A virus infection was shown by treating cells in culture or mice that were infected with influenza A virus with the ROS inhibitor N-acetyl-l-cysteine; this resulted in a significant decrease in IL-1β production 11 . However, NLRP3 activation triggered by silica, MSU crystals or ATP-induced activation of the purinergic receptor ligand-gated ion channel P2X7R seems to be normal in macrophages from mice that lack the NADPH oxidase subunit gp91phox 40 . Moreover, increased ROS production in superoxide dismutase 1 (SOD1)-deficient macrophages was recently found to inhibit, rather than promote, caspase-1 activation 41 . The destabilization and rupture of phago-lysosomal compartments, which then release endogenous mediators into the cytosol, has also been suggested to activate the NLRP3 inflammasome 42 . It is possible that these potential mechanisms of indirect NLRP3 activation are not mutually exclusive 43 and additional studies are required for further validation.
Alternatively, TLRs have been proposed to activate the NLRP3 inflammasome directly 44 . However, most reports indicate that TLR signalling or ROS alone is insufficient for NLRP3 inflammasome activation and for the production of significant amounts of IL-1β and/ or IL-18 (REFS 45, 46) . So, a two-signal hypothesis for inflammasome activation has emerged in which production of pro-IL-1β and pro-IL-18 is regulated independently of caspase-1 activation; only when signals for both pro-IL-1β and pro-IL-18 production and caspase-1 activation are received are significant amounts of active IL-1β and IL-18 produced. In the case of virus infection, dual signalling cues are common. For example, in influenza A virus infection, viral RNA triggers signalling through TLR3 or TLR7 and during virus entry into the host cell cytoplasm, endosomes are compromised, resulting in the release of ions and ROS into the cytosol. Recently, the ability of influenza A virus to activate NLRP3 through ion fluxes was found to be mediated by the M2 ion channel of the virus 36 . After infection, the virus-encoded M2 channel is expressed in the secretory compartment of the host cell, including the trans-Golgi network. The ion-channel activity of M2 enables the export of protons from acidified Golgi, which triggers the activation of the NLRP3 inflammasome in the cytosol. In this case, M2 expression alone was sufficient to activate the NLRP3 inflammasome 36 . Vaccinia virus was also shown to require both TLR2-dependent production of pro-IL-1β and endocytic internalization of the virus for robust IL-1β production mediated by the NLRP3 inflammasome 33 . The fact that multiple pathogens and danger signals activate the NLRP3 inflammasome has probably led to evolutionary pressures to develop a precise regulatory mechanism for the production of active IL-1β and IL-18. The requirement for two activating signals -one signal to produce the pro-form of these two cytokines and a second signal to activate their processing by the inflammasome -might allow for sensing a wide range of PAMPs and DAMPs while at the same time preventing unwanted inflammation by accidental activation of this pathway.
The RIG-I inflammasome. RIG-I, a member of the RLR family, has been shown to induce type I IFN production through the mitochondrial adaptor protein MAVS, followed by signalling through TNF receptor-associated factor 3 (TRAF3) and TRAF6, inhibitor of NF-κB kinase-ε (IKKε), and IFN response factor 3 (IRF3) and IRF7 (REFS 50, 51) . Several studies have examined the role of RIG-I during RNA virus infections in vitro, including infections with Newcastle disease virus, VSV, Sendai virus, hepatitis C virus, Japanese encephalitis virus (JEV), influenza A virus, rabies virus, measles virus and RSV [52] [53] [54] [55] [56] [57] [58] [59] (TABLE 1) . In vivo, RIG-I-deficient mice have only been studied in the context of JEV infection and were found to be highly susceptible to infection with this virus 53 . Owing to the difficulty in generating RIG-Ideficient mice, the role of RIG-I in the response to many other viruses has yet to be examined in vivo.
Another member of the RLR family is melanoma differentiation-associated antigen 5 (MDA5); this RNAsensing cytosolic PRR has also been shown to recognize RNA virus infection. Some debate has arisen over the past few years concerning exactly which RNA species RIG-I and MDA5 recognize. Recent work identified full-length virus genomes as the most important RIG-I agonist in cells that were infected with influenza virus and Sendai virus 60 . These studies also indicated that nongenomic viral transcripts, short replication intermediates and cleaved self-RNA do not contribute substantially to type I IFN induction in cells that are infected with negative-strand RNA viruses. Rather, ssRNA viral genomes bearing 5ʹ-triphosphates are the natural RIG-I agonists that trigger cell-intrinsic innate immune responses during viral infection. In the case of MDA5, the RNA species that is detected seems to be specific dsRNA intermediates that are produced during infection with positivestrand RNA viruses, particularly by members of the picornavirus family such as EMCV 53, 61 , but also by flaviviruses such as WNV 62 and Dengue virus 63 . Until recently, RIG-I was thought to be solely involved in the induction of type I IFNs through recruitment of the adaptor MAVS and activation of the transcription factors IRF3 and IRF7 (REF. 2). However, two recent reports show that RIG-I can also trigger IL-1β and/or IL-18 production through caspase-1 and caspase-3 activation 16, 64 . RIG-I activation by transfected 5ʹ-triphosphate RNA or VSV infection resulted in the production of pro-IL-1β through a MAVS-CARD9-NF-κB signalling pathway. In response to the same stimuli, RIG-I also directly activated the inflammasome pathway by recruiting caspase-1 through the adaptor ASC. This inflammasome activation pathway is not universal for all RLRs as MDA5 does not interact with ASC. These findings indicate that RIG-I might be able to mediate crosstalk between the type I IFN and inflammasome pathways. With regard to this crosstalk, RIG-I might singlehandedly mediate the dual signalling that is discussed above to be needed for NLRP3 inflammasome activation, as RIG-I can mediate MAVS signalling to induce NF-κB activation and pro-IL-1β production, as well as form an inflammasome and activate caspase-1. However, this possibility will require additional research. 
K63-linked polyubiquitylation
Ubiquitin is a highly conserved 76 kDa protein that is ligated to many proteins in both monomeric and polymeric forms. The two most common ubiquitin polymer chains are linked through an isopeptide bond between glycine-76 and either lysine-48 (K48) or lysine-63 (K63). K63-linked polyubiquitylation results in signals that are related to intracellular trafficking, cell signalling, ribosomal biogenesis and DNA damage repair. There are also reports that K63-linked polyubiquitin chains are involved in proteasome-independent proteolysis through autophagy.
The AIM2 inflammasome. AIM2 belongs to a family of proteins that includes at least six members in mice (IFI202, IFI203, IFI204, IFI205, PYHIN1 and AIM2) and four members in humans (IFI16, MNDA, IFIX and AIM2). These IFI200 family members (also known as HIN200 proteins) are IFN-inducible proteins with a 200-amino-acid repeat at the C-terminus, which is known as the HIN domain, and an N-terminal PYD. Four groups recently identified AIM2 as a cytosolic sensor that binds dsDNA through its C-terminal HIN domain [17] [18] [19] [65] [66] [67] . Similar to NLRP3, the AIM2 N-terminal PYD motif can recruit ASC and thereby caspase-1. Cytosolic dsDNA from both viruses and bacteria can function as a ligand to activate the AIM2 inflammasome 19, 37 . These observations were recently confirmed using AIM2-deficient mice 65, 68 . Macrophages from AIM2-deficient mice were defective in caspase-1 activation and the induction of pyroptosis in response to liposome-delivered cytosolic DNA. Furthermore, AIM2 was also required for the activation of caspase-1 in response to infection with vaccinia virus or mouse cytomegalovirus (MCMV) in cell culture 65, 68 (TABLE 1) . Aim2 -/-mice that were infected with MCMV were defective in IL-18 and IFNγ production and their NK cells, in particular, produced less IFNγ after restimulation compared with littermate controls 65 . Because activation of the AIM2 inflammasome not only leads to the generation of pro-inflammatory cytokines, but also to the elimination of infected cells through pyroptosis, AIM2 is likely to be important for the efficient clearance of viral infections. Indeed, Aim2 -/-mice had higher MCMV titres than control mice, probably as a result of decreased pyroptosis and NK cell activity 65 , although the independent contribution of both of these factors remains to be determined.
So, studies in AIM2-deficient mice have provided conclusive evidence for a crucial role of the AIM2 inflammasome in the recognition of cytosolic DNA and of infection with vaccinia virus and MCMV 65 . Furthermore, AIM2 was suggested to be important for the immune response against additional viruses that produce cytosolic DNA during their lifecycle (such as adenovirus and perhaps ssRNA retroviruses, which reverse transcribe their RNA into dsDNA in the cytoplasm). Intriguingly, this same paper reported that the dsDNA virus HSV1 did not require AIM2 for inflammasome activation 65 . These results could indicate that AIM2 is unable to recognize certain DNA viruses or that some viruses have evolved the ability to inhibit AIM2 signalling or to block AIM2-mediated recognition of their viral genomic DNA. Additional research will be needed to determine whether all families of DNA viruses are recognized by AIM2 and what factors control AIM2-mediated recognition and signalling.
NLRs in type I IFN responses
Although most NLRs are thought to be involved in either NF-κB and MAPK signalling or inflammasome activation and IL-1β and IL-18 production, recent studies have revealed a new and unexpected role for NLRs in type I IFN production. Type I IFNs were originally described as antiviral agents and comprise multiple IFNα molecules (13 subtypes in humans) and one IFNβ molecule 69, 70 . IFNβ expression is needed to exert positivefeedback control over the induction of IFNα genes 71 and to transduce intracellular signals through the common receptor IFNAR1-IFNAR2, leading to further enhancement of type I IFN gene induction through a complex of signal transducer and activator of transcription 1 (STAT1)-STAT2 and IRF9 (also known as ISGF3) 71 . Type I IFNs are important components of the antiviral innate immune system and might be responsible for driving broad cellular antimicrobial activity in general. The following is a brief description of the newly discovered roles of NLRs in type I IFN responses.
NOD2.
The NLR family member NOD2 senses bacterial molecules that are produced during the synthesis and/or degradation of peptidoglycan. This results in the recruitment of the downstream adaptor molecule RIPK2 through homotypic CARD interactions. This CARDcontaining serine-threonine kinase directly binds and promotes the K63-linked polyubiquitylation of the regulator IKKγ and activation of the kinase transforming growth factor-β-activated kinase 1 (TAK1) 72, 73 , which are prerequisites for the activation of the IKK complex. IKK activation results in degradation of the NF-κB inhibitor IκBα and the subsequent translocation of NF-κB to the nucleus, where transcription of NF-κB-dependent target genes, such as those encoding IL-6 and TNF, occurs. In addition to activation of the NF-κB pathway, NOD2 stimulation results in activation of the MAPKs p38, ERK and JNK 74, 75 . The CARD-containing adaptor protein CARD9 was found to be important for the activation of p38 and JNK downstream of NOD2, whereas it was dispensable for NF-κB activation 76 . Nevertheless, the NF-κB and MAPK pathways are thought to cooperate to upregulate the expression of pro-inflammatory molecules, such as IL-1β, TNF and IL-6, that stimulate both innate and adaptive immune responses. In addition, NOD2 has been shown to induce a type I IFN response to the intracellular bacterium Mycobacterium tuberculosis 77 . In this context, it was shown that the recognition of unique peptidoglycans from M. tuberculosis by NOD2 resulted in activation of a RIPK2-and IRF5-mediated signalling cascade that culminated in type I IFN production.
Recent studies have examined the role of NOD2 in response to ssRNA using a transfection assay that is designed to detect activation of the transcription factor IRF3, which is involved in the production of type I IFNs 7 . Both synthetic ssRNA and ssRNA viral genomes activated IRF3 in a NOD2-and MAVS-dependent manner 7 . The importance of NOD2 in antiviral defence was shown by the decreased type I IFN production and increased pathogenesis, lung disease and virus susceptibility of NOD2-deficient mice that were infected with RSV. Similarly, macrophages and mice that lacked NOD2 had decreased IRF3 phosphorylation and production of type I IFNs in response to influenza A and parainfluenza viruses 7 . Furthermore, Nod2
-/-cells were deficient in their ability to inhibit VSV replication 7 . This work indicated that NOD2 functions as a viral PRR that is important for the production of type I IFNs in response to RNA viruses; similar to RIG-I, it seems that NOD2 can trigger multiple signalling pathways in response to cytoplasmic pathogens. Furthermore, RSV infection was shown to result in NOD2 relocalization to mitochondria, where it binds to MAVS 7 . It is therefore likely that NOD2 binding to peptidoglycan induces the recruitment and activation of RIPK2, whereas binding of NOD2 to ssRNA results in mitochondrial relocalization of NOD2 and the activation of MAVS-dependent pathways (FIG. 1) . It should be noted, however, that NOD2 was not shown to bind ssRNA directly and only to be required for ssRNAmediated induction of type I IFNs. How NOD2 can recognize the presence of both bacterial peptidoglycan and viral ssRNA and the biochemical mechanism that links MAVS to IRF3 activation during NOD2 signalling require further analysis.
Another role for NOD2 during virus infection was recently shown by the observation that NOD2 interacts with 2ʹ-5ʹ-oligoadenylate synthetase type 2 (OAS2) 78 . This interaction was shown to positively regulate the enzymatic activity of OAS2 in response to poly(I:C) and this resulted in increased degradation of RNAs by RNAse L. OAS2 is required for the activation of RNAse L, which degrades viral and cellular RNA and inhibits virus replication 79 . At the same time, RNAse L provides a positive feedback mechanism for type I IFN production by generating new PAMPs for recognition by RIG-I and MDA5 (REF. 80 ). These reports further implicate NOD2 in the efficient induction of type I IFNs in response to virus infection. NLRX1. NLRX1 is the only NLR known so far to localize to mitochondria. Indeed, this NLR family member contains a mitochondrial targeting sequence in its N-terminus 8, 9, 81 . Overexpression of NLRX1 resulted in inhibition of RIG-I signalling that was induced by synthetic RIG-I ligands and viruses, such as Sendai virus or Sindbis virus. Depletion of NLRX1 through the use of siRNA amplified virusinduced type I IFN production and decreased viral replication. However, the precise subcellular localization of NLRX1 in mitochondria remains to be determined. In one study, NLRX1 was found in close proximity to MAVS, which is known to be associated with the outer mitochondrial membrane. Physical association between MAVS and NLRX1 prevented viral RNA-induced type I IFN responses and NF-κB activation, indicating that NLRX1 is a negative regulator of RLR signalling 9 . A second study contested the localization of NLRX1 to the outer mitochondrial membrane and showed that NLRX1 fully translocates to the mitochondrial matrix 8 . Accordingly, NLRX1 amplified NF-κB and JNK signalling by augmenting ROS production in mitochondria in response to poly(I:C) treatment 81 . Although the mechanism of NLRX1 function is unclear and its positive or negative role in antiviral signalling is under debate, the mitochondrial localization of NLRX1 seems to be essential for regulating its activity. Further studies will be required to resolve the precise localization of NLRX1 in mitochondria, and to determine whether NLRX1 has a pro-or anti-inflammatory effect or whether the role of NLRX1 is context dependent. The generation of NLRX1-deficient mice will be important to determine the physiological role of this unique NLR family member.
NLRC5. Similar to NLRX1, NLRC5 is an atypical NLR family member in that it contains a C-terminal effector domain that is predicted to adopt a death domain fold without obvious homology to the CARD and PYD motifs that are found in most NLRs 82 . Furthermore, the LRR domain of NLRC5 is the longest of all the NLRs and comprises more than 1,000 residues. It is thought to be arranged in a helical structure rather than the 'horseshoe' fold that is typical for most LRR domains 83 . One study recently reported that NLRC5 protein is primordially expressed in haematopoietic tissues and cells of the myeloid and lymphoid lineages 83 , whereas another study showed a ubiquitous expression pattern for NLRC5 with lowest expression levels found in lymphoid tissue and leukocytes 84 . NLRC5 was recently shown to be specifically upregulated by IFNγ and was implicated in inducing IFNdependent gene transcription [83] [84] [85] [86] . This suggests that it might have an important role in antiviral immune responses, although the precise molecular mechanism remains to be determined. Knockdown of endogenous NLRC5 expression in THP-1 cells and in primary human dermal fibroblasts impaired type I IFN responses, as shown by decreased IFNβ and CC-chemokine ligand 5 (CCL5) production, and decreased IFNB1 and CXCL10 (also known as IP-10) mRNA induction, after Sendai virus infection and poly(I:C) stimulation 83 . In agreement with this, NLRC5 knockdown decreased the induction of IFNα in human foreskin fibroblast cells that were stimulated with poly(I:C) or infected with CMV 84 . In contrast to these two reports, it was recently suggested that NLRC5 is a negative regulator of NF-κB signalling and type I IFN production during viral infection 87 . These results were comparable to another recent study that showed that siRNA-mediated knockdown of Nlrc5 in a mouse macrophage cell line resulted in increased NF-κB signalling and increased type I IFN, IL-6, IL-1β and TNF production 85 . Furthermore, an inhibitory role for NLRC5 in MHC class I and CD40 expression was also shown in this study. However, another study described NLRC5 as a positive regulator of MHC class I expression together with other genes that are involved in antigen presentation 86 . Although the above studies are contradictory in many respects, the ability of IFNγ to upregulate NLRC5 expression is consistent. The generation of NLRC5-deficient mice will undoubtedly contribute to resolving these apparent discrepancies and to characterizing the physiological role of this NLR in antiviral immune signalling.
NLRs and inflammasomes recognize specific non-self motifs in viral products, the viral replication programme (a cytosolic phase of genome amplification and/or mRNA metabolism), viral protein expression or the ion-channel activity of viruses. After virus infection, multiple signalling pathways are activated simultaneously or sequentially in the host cell to eliminate the invading pathogen and to prevent the establishment of a persistent infection. This activation of distinct and shared signalling pathways leads to pathway crosstalk as described above and eventually determines the specific immune response that is directed at clearing the virus. As the host has evolved factors and strategies for detecting and responding to viral infection, viruses have developed countermeasures to inhibit these processes. Owing to genomic constraints, many pathogenic viruses focus their disruptive efforts on a small number of host targets that are key players in the antiviral response. Thus, common host molecules that connect virus recognition to downstream effectors and inflammatory cytokine expression are usually targeted by viral immune evasion proteins. An overview of the mechanisms by which viruses block NLR and inflammasome signalling is provided below.
Virus immune evasion of NLRs and inflammasomes
In the evolutionary arms race between a pathogen and its host, the host has undergone selection for various mechanisms to detect the presence of viruses and closely regulates the production of master cytokines such as IL-1β and IL-18 by the inflammasome. In response, viruses have undergone selective pressure to evade activation of the inflammasome. Several viruses are known to encode proteins that interfere with inflammasome signalling (TABLE 2) . Inflammasome signalling is disrupted at the level of the adaptor protein ASC or caspase-1 itself, as both of these molecules are activated downstream of multiple NLRs, as well as downstream of AIM2 and RIG-1 inflammasomes.
The large genomes of poxviruses encode multiple inhibitors that interfere with innate and adaptive immunity 88 . Bioinformatics studies show that many poxviruses encode a putative PYD-containing protein that is hypothesized to interact with ASC; however, the only examples that have been studied in detail are the myxoma virus M13L-PYD and Shope Fibroma virus S013L proteins [89] [90] [91] . M13L-PYD is required for the pathogenesis of myxoma virus and deletion of this protein results in severe virus attenuation in vivo. This is shown by a decrease in viraemia owing to inefficient replication in lymphocytes and leukocytes and increased inflammation at the initial site of infection, which together lead to more rapid resolution of disease. In vitro, infection of cells with myxoma virus that lacks M13L-PYD leads to increased activation of caspase-1 and increased levels of IL-1β and IL-18; these findings indicate that M13L-PYD has an immunosuppressive function 91 . M13L-PYD and S013L associate with ASC through direct PYD-PYD interactions. Expression of either M13L-PYD or S013L alone inhibits caspase-1 activation and IL-1β production downstream of the NLRP3 inflammasome in cell culture 90, 91 . Poxvirus PYD-containing proteins can therefore inhibit inflammasome activation at the level of the adaptor protein ASC and prevent PRRs from activating caspase-1 in virus-infected cells. In addition, ASC might have several caspase-1-independent immune functions, such as the activation of T cells and lymph node cells; it is therefore possible that poxvirus PYD-containing proteins block inflammation by inhibiting these processes as well.
Poxviruses also encode various serpin-like protease inhibitors (SPIs) that inhibit caspase-1. For example, CrmA (also known as SPI-2) of cowpox virus is a wellknown caspase-1 inhibitor. CrmA deficiency decreases the number and severity of pox lesions on the allantoic membrane when cowpox virus is grown in chicken eggs 92, 93 . Respiratory tract infection of mice with cowpox virus or rabbit poxvirus mutants that lack CrmA results in decreased inflammation and viral loads compared with wild-type virus 94, 95 . After intradermal inoculation with cowpox virus, more rapid virus clearance and a more robust inflammatory response are observed with virus lacking CrmA 96 . It is interesting to note that no differences in IL-1β levels were observed in the lungs of C57BL/6 mice that were infected with wildtype cowpox virus versus mutant virus lacking CrmA 96 , even though in vitro studies indicate that CrmA can inhibit IL-1β production and secretion.
Other poxviruses also encode SPI homologues, such as Serp2 in myxoma virus 97 . Deletion of Serp2 results in severe attenuation of myxoma virus infection in rabbits 98 . Some vaccinia viruses also encode an SPI-2 protein. However, deletion of vaccinia virus SPI-2 had no effect on IL-1β-induced fever responses in infected mice and vaccinia virus SPI-2 mutants were not attenuated in vivo 94, 95 . Instead, fever reduction and attenuated weight loss in vaccinia virus-infected mice depended on vaccinia virus-encoded IL-1β scavenger receptor (vIL-1βR) 94 . Several poxviruses also encode an IL-18-binding protein that blocks IL-18-induced signalling 99 . It is becoming clear that poxviruses have evolved various inflammasome inhibitors and molecules that interfere with downstream signalling induced by the inflammasome products IL-1β and IL-18.
However, viral inflammasome inhibitors are not limited to poxviruses. The NS1 protein of influenza A/ PR/8/34 H1N1 virus prevents caspase-1 activation and IL-1β production 100 . The N-terminus of this NS1 protein was also suggested to interfere with inflammasome activation, although the details remain unclear. Influenza A/PR/8/34 H1N1 virus that lacks the N-terminus of NS1 is attenuated in cell culture and induces higher levels of IL-1β and cell death. Interestingly, inhibition of the dsRNA-dependent protein kinase PKR also decreases IL-1β production in cells that are infected with NS1-mutant influenza A/PR/8/34 H1N1 virus. Although these results do not provide a clear inhibitory mechanism for NS1, they do show the importance of this protein for virus replication. However, the ability of NS1 to block caspase-1 activation seems to be strain specific, as NS1 from highly pathogenic H5N1 bird influenza A virus activates caspases and induces apoptosis 101 . One possible explanation for the ability of H5N1 influenza A virus to grow despite activating caspases is that it downregulates NLRP3 and IL-1β expression levels by 24 hours after infection 102 and therefore H5N1 virus might not require inhibition of caspase-1 to suppress inflammation. By contrast, influenza A/PR/8/34 H1N1 virus has been shown to upregulate the expression of inflammasome components 11 and might therefore require NS1-mediated inhibition of caspase-1 to prevent inflammation and to replicate successfully.
It is probable that there are other viral immune evasion pathways that target inflammasome components. Therapeutic interventions that are designed to target the virus-host interface of such immune evasion strategies to restore the functions of PRRs and their signalling pathways will offer the potential to restore innate immune induction and inflammatory programmes that initiate immunity for the control of virus infection.
Concluding remarks
Host proteins that are involved in the recognition of virus infection have only recently been identified and the initial characterization of their roles in this intricate system is only just beginning to be understood. Identification of the NLR and RLR family of pathogen sensors in the past several years has provided important information concerning the cellular recognition of viruses. It is clear from the information presented here that NLRs and inflammasomes are necessary for the innate inflammatory control of virus infection, as well as for healing responses. In addition, the fact that multiple viruses encode inflammasome inhibitors is consistent with the importance of this pathway for inhibiting virus replication. However, our knowledge of inflammasome biology is still in its infancy and many questions remain to be answered. Specifically, how are these pathways regulated? Is there crosstalk with other PRRs that recognize the same pathogen? What is the physiological significance of each of these systems and which viral triggers are responsible for their activation? As research continues into the role of NLRs and inflammasomes in antiviral immunity, it is probable that the list of PRRs that are involved and the viruses that activate and suppress NLR and inflammasome signalling will continue to grow.
